BioStar Capital
BioStar Capital, based in Michigan, backs healthtech, life sciences, and deep tech firms, with its latest $130.3 million fund supporting investments like Ablative Solutions and Foldax.
Who you would pitch at BioStar Capital
6 people on the investing team, 4 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.
Check size not reported yet.
Bars: how many firms in the atlas report each band. Highlighted: this firm.No recent activity since September 2026. Quiet does not mean closed.
Weekly count of activity updates. Activity is not a confirmed deal.Before you pitch
Notable investments
In their words
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAlert me when BioStar Capital is active
One email when this firm shows new activity. Nothing else.
Questions
What stage does BioStar Capital invest in?
BioStar Capital has not reported an entry stage.
How much does BioStar Capital invest?
BioStar Capital has not reported a check size.
Does BioStar Capital lead rounds?
BioStar Capital has not reported a lead preference.
Who are the partners at BioStar Capital?
Alan Davis (Managing Director), Louis Cannon (Founder, Senior Managing Director), Mark Toland (Managing Director), William H. Kucheman (Managing Director).
Is BioStar Capital active right now?
No recent activity since September 2026.
Work at BioStar Capital? Claim or correct this profile.